These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34414910)

  • 21. A simulation of geographic distribution for the emergence of consequential SARS-CoV-2 variant lineages.
    Akaishi T; Ishii T
    Sci Rep; 2022 Jun; 12(1):9999. PubMed ID: 35705624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation and multilevel selection of SARS-CoV-2.
    Blackstone NW; Blackstone SR; Berg AT
    Evolution; 2020 Oct; 74(10):2429-2434. PubMed ID: 32880957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological analysis of the emergence and disappearance of the SARS-CoV-2 Kappa variant within a region of British Columbia, Canada.
    Ghafari C; Benusic M; Prystajecky N; Sbihi H; Kamelian K; Hoang L
    Can Commun Dis Rep; 2022 Jan; 48(1):22-26. PubMed ID: 35273466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics and control measures of 2019 novel coronavirus Delta variant of concern].
    Ren S; Wang X; Zhao X; Qin B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1141-1144. PubMed ID: 34839879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Mutant Peptides of SARS-CoV-2 Variants by LC/MS in the DDA Approach Using an In-House Database.
    Rajoria S; Halder A; Tarnekar I; Pal P; Bansal P; Srivastava S
    J Proteome Res; 2023 Jun; 22(6):1816-1827. PubMed ID: 37093804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visibility, wind speed, and dew point temperature are important factors in SARS-CoV-2 transmissibility.
    Zhou D; Wang EW; Hou C; Liao J; Zhang J; Fu X; Chen J; Xing Y; Hong W; Zhang Z; Chen Y; Feng H; Chen Y; Yang Q; Zhang H; Li Z; Feng W; Wang T; Lin Z; Zhang C; Yang K; Lu W; Wang J; Chen Y
    Pulm Circ; 2022 Apr; 12(2):e12081. PubMed ID: 35514785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta coronavirus variant: scientists brace for impact.
    Callaway E
    Nature; 2021 Jul; 595(7865):17-18. PubMed ID: 34158664
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular detection of SARS-CoV-2 eta VOI in Northern Italy: a case report.
    Broccolo F; Giovanetti M; Colombo A; Perrelli N; Bussini A; Cavalli S; Ciccozzi M; Zollo M
    Clin Chem Lab Med; 2022 Feb; 60(3):61-63. PubMed ID: 34854655
    [No Abstract]   [Full Text] [Related]  

  • 29. Global clinical trial mobilization for COVID-19: higher, faster, stronger.
    Beall RF; Hollis A
    Drug Discov Today; 2020 Oct; 25(10):1801-1806. PubMed ID: 32777537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Paradigm Shift in the Combination Changes of SARS-CoV-2 Variants and Increased Spread of Delta Variant (B.1.617.2) across the World.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    Aging Dis; 2022 Jun; 13(3):927-942. PubMed ID: 35656100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early detection of variants of concern via funnel plots of regional reproduction numbers.
    Milanesi S; Rosset F; Colaneri M; Giordano G; Pesenti K; Blanchini F; Bolzern P; Colaneri P; Sacchi P; De Nicolao G; Bruno R
    Sci Rep; 2023 Jan; 13(1):1052. PubMed ID: 36658143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayesian inference across multiple models suggests a strong increase in lethality of COVID-19 in late 2020 in the UK.
    Pietzonka P; Brorson E; Bankes W; Cates ME; Jack RL; Adhikari R
    PLoS One; 2021; 16(11):e0258968. PubMed ID: 34818345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological characteristics of the SARS-CoV-2 Theta variant (P.3) in the Central Visayas region, Philippines, 30 October 2020-16 February 2021.
    Haw NJL; Cañal EMR; Zuasula J; Loreche MJ; Bernadas J
    Western Pac Surveill Response J; 2022; 13(1):1-3. PubMed ID: 35355903
    [No Abstract]   [Full Text] [Related]  

  • 34. An advocate for Africa.
    Wadman M
    Science; 2022 Oct; 378(6615):17-21. PubMed ID: 36201592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update of the epidemiological distribution of COVID-19 variants: a review article.
    Azevedo TCP; Melo VSC; Silva RMD; Barbosa BGH; Christofoletti LZM; Nascimento GMCSD; Oliveira GSL; Barbosa FT; Sousa-Rodrigues CF; Ramos FWDS
    Rev Assoc Med Bras (1992); 2021 Sep; 67(9):1368-1371. PubMed ID: 34816936
    [No Abstract]   [Full Text] [Related]  

  • 36. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines.
    Mohammadi M; Shayestehpour M; Mirzaei H
    Braz J Infect Dis; 2021; 25(4):101606. PubMed ID: 34428473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination.
    Chiu NC; Chi H; Tu YK; Huang YN; Tai YL; Weng SL; Chang L; Huang DT; Huang FY; Lin CY
    Expert Rev Vaccines; 2021 Oct; 20(10):1211-1220. PubMed ID: 34415818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology.
    Caldwell JM; Le X; McIntosh L; Meehan MT; Ogunlade S; Ragonnet R; O'Neill GK; Trauer JM; McBryde ES
    Paediatr Respir Rev; 2021 Sep; 39():32-39. PubMed ID: 34417121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: A systematic review and meta-analysis.
    Du X; Shi L; Cao W; Zuo B; Zhou A
    PLoS One; 2021; 16(8):e0256429. PubMed ID: 34415962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.